Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study of the SUI-100™ for the Treatment of Stress Urinary Incontinence (SUI): A Nonsignificant Risk (NSR) Device (SaHARA) Study

NCT06862648 is registered in ClinicalTrials.gov with Acoustic Wave Cell Therapy, Inc. as lead sponsor.

NCT NCT06862648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06862648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study of the SUI-100™ for the Treatment of Stress Urinary Incontinence (SUI): A Nonsignificant Risk (NSR) Device (SaHARA) Study
Lead sponsor
Acoustic Wave Cell Therapy, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 25, 2025
Completion date
November 9, 2026
Enrollment
130 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

stress urinary incontinence (sui)